This session takes a broader view of treatment success, exploring how newer non-factor approaches are changing haemophilia care and addressing outcomes beyond bleed control, including quality of life.

Why attend? This session will help doctors understand the evolving approach to haemophilia treatment, beginning with the role of factor replacement and the practical challenges that can affect treatment outcomes, including inhibitor development, venous access, adherence and breakthrough bleeds. Attendees will also gain an understanding of non-factor therapies and their potential role in addressing some of these challenges while improving patient outcomes.